Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: An individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group

Journal of Clinical Oncology

Volumn 31, Issue 23, 2013, Pages 2854-2860

  Blanchard, Pierre ^a   Bourhis, Jean ^a   Lacas, Benjamin ^a   Posner, Marshall R ^c   Vermorken, Jan B ^d   Hernandez, Juan J Cruz ^e   Bourredjem, Abderrahmane ^a   Calais, Gilles ^b   Paccagnella, Adriano ^g   Hitt, Ricardo ^f   Pignon, Jean Pierre ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^e Spanish Head and Neck Cancer Cooperative Group ^*  (Spain)

^f HM Hospitales Centro Integral Oncológico Hospital de Madrid Clara Campal   (Spain)

^g OSPEDALE DELL'ANGELO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; TAXANE DERIVATIVE; ANTINEOPLASTIC AGENT; BRIDGED COMPOUND; TAXANE; TAXOID;

ADVANCED CANCER; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; COMPARATIVE STUDY; CONFERENCE PAPER; DRUG EFFICACY; HEAD AND NECK CANCER; HUMAN; INDUCTION CHEMOTHERAPY; META ANALYSIS; NEUTROPENIA; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; DISEASE FREE SURVIVAL; HEAD AND NECK NEOPLASMS; MIDDLE AGED; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRIDGED COMPOUNDS; CISPLATIN; DISEASE-FREE SURVIVAL; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; INDUCTION CHEMOTHERAPY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TAXOIDS; TREATMENT OUTCOME;

EID: 84886807943     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.47.7802     Document Type: Conference Paper

References (21)

1. Argiris A, Karamouzis MV, Raben D, et al: Head and neck cancer. Lancet 371:1695-1709, 2008.
2. Pignon JP, le MaÎtre A, Maillard E, et al: Meta-Analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17, 346 patients. Radiother Oncol 92:4-14, 2009.
3. Blanchard P, Hill C, Guihenneuc-Jouyaux C, et al: Mixed treatment comparison meta-Analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer. J Clin Epidemiol 64:985- 992, 2011.
4. Pignon JP, Bourhis J, Domenge C, et al: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-Analyses of updated individual data-MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355:949-955, 2000.
5. Forastiere AA, Zhang Q, Weber RS, et al: Longterm results of Intergroup RTOG 91-11: A comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31:845-852, 2013.
6. Hitt R, Lopez-Pousa A, Martínez-Trufero J, et al: Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23:8636-8645, 2005.
7. Hitt R, Grau JJ, Lopez-Pousa A, et al: Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) versus CRT alone as first-line treatment of unresectable locally advanced head and neck cancer (LAHNC). J Clin Oncol 27:303s, 2009 (suppl; abstr 6009).
8. Lorch JH, Goloubeva O, Haddad RI, et al: Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: Long-Term results of the TAX 324 randomised phase 3 trial. Lancet Oncol 12:153-159, 2011.
9. Paccagnella A, Ghi MG, Loreggian L, et al: Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: A phase II randomized study. Ann Oncol 21:1515-1522, 2010.
10. Pointreau Y, Garaud P, Chapet S, et al: Randomized trial in induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101:498-506, 2009.
11. Vermorken JB, Remenar E, van Herpen C, et al: Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695- 1704, 2007.
12. Stewart LA, Clarke MJ: Practical methodology of meta-Analyses (overviews) using updated individual patient data: Cochrane Working Group. Stat Med 14:2057-2079, 1995.
13. Yusuf S, Peto R, Lewis J, et al: Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 27: 335-371, 1985.
14. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31, 000 recurrences and 24, 000 deaths among 75, 000 women-Early Breast Cancer Trialists' Collaborative Group. Lancet 339:1- 15, 1992.
15. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-Analysis. Stat Med 21:1539- 1558, 2002.
16. Schemper M, Smith TL: A note on quantifying follow-up in studies of failure time. Control Clin Trials 17:343-346, 1996.
17. Stewart LA, Parmar MK: Meta-Analysis of the literature or of individual patient data: Is there a difference? Lancet 341:418-422, 1993.
18. Posner MR, Hershock DM, Blajman CR, et al: Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705- 1715, 2007.
19. Lefebvre JL, Pointreau Y, Rolland F, et al: Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: The TREMPLIN randomized phase II study. J Clin Oncol 31:853-859, 2013.
20. Cohen EE, Karrison T, Kocherginsky M, et al: DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN). J Clin Oncol 30:356s, 2012 (suppl; abstr 5500).
21. Haddad R, O'Neill A, Rabinowits G, et al: Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial. Lancet Oncol 14:257- 264, 2013.